- Employees
- 1–10
- Business Model
- B2B
- Website
- ilof.tech
- Total Funding
- $5.0M
- Last Round
- $5.0M SeedJul 2022
- Rounds
- 1
About
AI-powered photonics platform for blood-based screening and biomarker identification for Alzheimer's and other diseases.
Summary
iLoF is an Artificial Intelligence company. It has raised $5.0M in total across 1 round, most recently a $5.0M Seed round in Jul 2022. Investors include Faber Ventures and EIT Health.
Tech & App Stack
4 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jul 2022
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company